Human skin is the natural source, place of metabolism, and target for vitamin D(3). The classical active form of vitamin D(3), 1,25(OH)(2)D(3), expresses pluripotent properties and is intensively studied in cancer prevention and therapy. To define the specific role of vitamin D(3) receptor (VDR) and its co-receptor retinoid X receptor alpha (RXRA) in genomic regulation, VDR or RXRA genes were silenced in the squamous cell carcinoma cell line A431 and treated with 1,25(OH)(2)D(3) at long incubation time points 24Â h/72Â h. Extending the incubation time of A431 WT (wild-type) cells with 1,25(OH)(2)D(3) resulted in a two-fold increase in DEGs (differentially expressed genes) and a change in the amount of downregulated from 37% to 53%. VDR knockout led to a complete loss of 1,25(OH)(2)D(3)-induced genome-wide gene regulation at 24Â h time point, but after 72Â h, 20 DEGs were found, of which 75% were downregulated, and most of them belonged to the gene ontology group "immune response". This may indicate the existence of an alternative, secondary response to 1,25(OH)(2)D(3). In contrast, treatment of A431 ÎRXRA cells with 1,25(OH)(2)D(3) for 24Â h only partially affected DEGs, suggesting RXRA-independent regulation. Interestingly, overexpression of classic 1,25(OH)(2)D(3) targets, like CYP24A1 (family 24 of subfamily A of cytochrome P450 member 1) or CAMP (cathelicidin antimicrobial peptide) was found to be RXRA-independent. Also, immunofluorescence staining of A431 WT cells revealed partial VDR/RXRA colocalization after 24Â h and 72Â h 1,25(OH)(2)D(3) treatment. Comparison of transcriptome changes induced by 1,25(OH)(2)D(3) in normal keratinocytes vs. cancer cells showed high cell type specific expression pattern with only a few genes commonly regulated by 1,25(OH)(2)D(3). Activation of the genomic pathway at least partially reversed the expression of cancer-related genes, forming a basis for anti-cancer activates of 1,25(OH)(2)D(3). In summary, VDR or RXRA independent genomic activities of 1,25(OH)(2)D(3) suggest the involvement of alternative factors, opening new challenges in this field.
Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)(2)D(3) in A431 squamous cell carcinoma.
剖析 VDR 和 RXRA 对 A431 鳞状细胞癌中 1,25(OH)2D3 基因组活性的影响
阅读:7
作者:Olszewska Anna M, Nowak Joanna I, Myszczynski Kamil, SÅominski Andrzej, Å»mijewski MichaÅ A
| 期刊: | Molecular and Cellular Endocrinology | 影响因子: | 3.600 |
| 时间: | 2024 | 起止号: | 2024 Mar 1; 582:112124 |
| doi: | 10.1016/j.mce.2023.112124 | 研究方向: | 细胞生物学 |
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
